Pharma Stocks

Nifty, Sensex open cautiously; banking, pharma stocks weigh

The Sensex, which had closed Monday’s session at 77,708.52, opened at 77,649.63 and was trading at 77,720.47, up 11.95 points…

Read More »

Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units

Cosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500…

Read More »

For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?

The iShares Global Healthcare ETF (IXJ 0.48%) provides broad global sector exposure, while VanEck Pharmaceutical ETF (PPH 1.00%) offers a…

Read More »

Ionis Pharmaceuticals Stock Slides 37% Over 8 Straight Down Days

A persistent slide in the biotech’s stock price prompts a closer look at the numbers behind the momentum. Ionis Pharmaceuticals…

Read More »

Natco Pharma shares surge 5% after US FDA’s tentative nod Olaparib tablets

Natco Pharma shares climbed as much as 4.5% on Monday, touching an intraday high of Rs 987.55 on the NSE,…

Read More »

Did Jazz’s Sleep and Oncology Pipeline Momentum Just Shift Jazz Pharmaceuticals’ (JAZZ) Investment Narrative?

In recent months, Jazz Pharmaceuticals has drawn fresh attention as investors reassess its sleep-disorder and oncology portfolios amid growing interest…

Read More »

Eisai (TSE:4523) Following Leqembi Home Dosing Approval Is The Alzheimer’s Upside Already Priced In

Eisai (TSE:4523) is back in focus after fresh Alzheimer’s data and a new at-home dosing option for Leqembi. These developments…

Read More »

Can Alnylam (ALNY) Turn Early Alzheimer’s RNAi Signals Into a Durable Neuroscience Investment Story?

Alnylam Pharmaceuticals recently presented at the Alzheimer’s Association International Conference 2026 in London, sharing Phase 1 and Phase 2 updates…

Read More »

Vertex Pharma stock steadies as cystic fibrosis franchise drives revenue and investors watch next da

Vertex Pharmaceuticals Inc. (ISIN US92532F1003) is best known for its cystic fibrosis therapies, and Vertex Pharma stock trades on Nasdaq…

Read More »

ANI Pharmaceuticals (ANIP) Stock Looks Fairly Valued With Strong Returns But Mixed Earnings

ANI Pharmaceuticals has delivered a strong 139.1% return over the past 5 years, yet at around US$79.20 the valuation checks…

Read More »